Thymosin Alpha-1: selected references HeartPep literature library, reviewed 2026-11-09 https://heartpep.com/us/research/library/thymosin-alpha-1 1. Wu J, Pei F, Zhou L, et al.; TESTS study collaborator group (2025). The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial BMJ. DOI: https://doi.org/10.1136/bmj-2024-082583 PMID: 39814420 Source: https://pubmed.ncbi.nlm.nih.gov/39814420/ Verification: Abstract / bibliographic record. 2. BMJ (2025). Correction: The efficacy and safety of thymosin α1 for sepsis (TESTS) BMJ. DOI: https://doi.org/10.1136/bmj.r1098 PMID: 40447307 Source: https://pubmed.ncbi.nlm.nih.gov/40447307/ Verification: Full text. 3. Wu J, Zhou L, Liu J, et al. (2013). The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial Critical Care. DOI: https://doi.org/10.1186/cc11932 PMID: 23327199 Source: https://pubmed.ncbi.nlm.nih.gov/23327199/ Verification: Abstract / bibliographic record. These are selected background references, not evidence that a HeartPep product or batch matches a studied preparation. Cite and assess the original papers.